melanoma

GSK’s MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Melanoma Misses First Co-Primary Endpoint
Yahoo
Thu, 09/5/13 - 08:15 am
GSK
melanoma
Agenus
With Vical Out, What's Next For The Melanoma Pipeline?
Seeking Alpha
Mon, 08/19/13 - 10:17 am
Vical
melanoma
Amgen
Celsion
OncoSec
Allovectin
ImmunoPulse
2 Biotechs Aim To Capitalize On The Treatment Of Melanoma
Seeking Alpha
Tue, 08/13/13 - 04:13 pm
melanoma
Amgen
OncoSec
Vical
TVEC
NeoPulse
Merck's Pipeline Of Drugs Should Make Up For Lost Sales To Generic Competition
Seeking Alpha
Mon, 08/12/13 - 09:11 am
Merck
generics
lambrolizumab
Odanacatib
melanoma
osteoporosis
non-small cell lung cancer
MannKind, Vical, GTx: Investors Predict Pivotal Clinical Trial Results
TheStreet.com
Mon, 08/5/13 - 07:23 am
MannKind
Vical
clinical trials
GTx
diabetes
Afrezza
melanoma
Allovectin-7
enobosarm
lung cancer-related muscle wasting
Merck jumps on melanoma treatment results
Marketwatch
Mon, 06/3/13 - 11:26 am
Merck
melanoma
lambrolizumab
ASCO
Bristol And Merck's Cancer Drugs Won ASCO. Five Slides Explain Why.
TheStreet.com
Mon, 06/3/13 - 10:20 am
nivolumab
Merck
melanoma
lambrolizumab
Bristol-Myers Squibb
ASCO
Merck Rushes Forward In Race To Market Cell Death Cancer Drugs
Forbes
Sun, 06/2/13 - 11:56 am
Merck
lambrolizumab
melanoma
Merck's Anti-PD1 Melanoma Drugs Shrinks Tumors In Half of Patients
The Street
Sun, 06/2/13 - 11:54 am
Merck
labrolizumab
melanoma
New Approvals Spark a Melanoma Drug Battle
Motley Fool
Sat, 06/1/13 - 12:48 pm
melanoma
GSK
Tafinlar
Mekinist
Roche
Bristol-Myers Squibb
3 FDA Stories You Missed This Week
Motley Fool
Sat, 06/1/13 - 12:46 pm
Merck
suvorexant
insomnia
sleep aid
hypnotics
Celgene
Abraxane
prostate cancer
Glaxo
Tafinlar
dabrafenib
melanoma
ASCO '13: Array Drug First to be Effective Against Melanoma of the Eye
The Street
Sat, 06/1/13 - 12:44 pm
Array Biopharma
melanoma
ocular melanoma
selumetinib
AstraZeneca
Bristol drug shrinks melanoma in 31 pct of trial patients
Reuters
Sat, 06/1/13 - 12:24 pm
nivolumab
Bristol-Myers Squibb
melanoma
Amgen melanoma drug improved survival by 21 pct in interim look
Reuters
Sat, 06/1/13 - 12:12 pm
Amgen
T-Vec
Talimogene Laherparepvec
melanoma
GlaxoSmithKline gains FDA OK on two genetically targeted skin cancer drugs
Fierce Biotech
Wed, 05/29/13 - 04:49 pm
FDA
GSK
melanoma
dabrafenib
trametinib
Promising Data on ONCY's Reolysin
Yahoo/Zacks
Sat, 05/25/13 - 11:51 am
Oncolytics
Reolysin
melanoma
metastatic melanoma
Bristol Myers Squibb And The New Wave Of Cancer Drugs
Seeking Alpha
Mon, 05/20/13 - 05:26 pm
Bristol-Myers Squibb
Merck
nivolumab
lambrolizumab
Roche
PD-L1
melanoma
cancer
lung cancer
[video]Will Amgen's Novel Drug Revolutionize Cancer Treatment?
Motley Fool
Mon, 05/20/13 - 05:19 pm
Amgen
Talimogene Laherparepvec
melanoma
Roche immunotherapy shows response over range of cancers
Reuters
Thu, 05/16/13 - 10:22 am
Roche
immunotherapy
MPDL3280A
melanoma
lung cancer
kidney cancer
Bristol-Myers Drug Cocktail Stymies Melanoma Tumors
Bloomberg
Thu, 05/16/13 - 08:49 am
melanoma
Bristol-Myers Squibb
nivolumab
Yervoy

Pages